Exclusivity. Subject to [Section 2.2] below, Biose agrees that during the Term it will manufacture and supply exclusively to Evelo (and to no third party) non-genetically modified, single Strain Product(s) intended for oral delivery. Biose shall not conduct any such activities (manufacture and supply of non genetically modified single Strain Product(s) intented for oral delivery) for any third party, or enable any third party to conduct any such activities.

Limitation. For clarity, [Section 2.2] below, Biose agrees that1] above does not prohibit Biose, during the Term it willTerm, from continuing to develop and manufacture and supply exclusively to Evelo (and to no third party)# non-genetically modified, single Strain Product(s)products intended for oral delivery.delivery for which development and clinical trials are financed by Biose, or # the Biose Strain(s); or # ​ and ​ for single Strain, orally delivered Products pursuant to ​. For clarity, Biose shall not agree to manufacture or otherwise conduct any such activities (manufacture and supply of non with respect to any other non-genetically modified single Strain Product(s) intentedProducts intended for oral delivery) for any third party, or enable any third party to conduct any such activities.delivery, except as expressly described above.